Looking ahead at the potential benefits of biotechnology-derived allergen therapeutics.
While biotechnology-derived allergen therapeutics show promise in improving the safety of immunotherapy, they may prove to have additional benefits in comparison to conventional allergenic extracts that deserve commentary. These issues range from product stability and compatibility to medical practice issues, which will be the focus of this article.
Behrmann
Jason
J
Programmes de bioéthique, Université de Montréal, C.P. 6128, succursale centre-ville, Montréal, Québec, H3C 3J7, Canada. jason.behrmann@mail.mcgill.ca